Sarah Marr

Can Electric Health Records be used to predict the risk of mental health conditions?

5th September 2024

Researchers from our BRC Data Science Theme have contributed to an article on the use of Electronic Health Records (EHRs) to facilitate personalised treatments for psychiatric conditions. Clinical prediction models…

New drug to treat patients in the early stages of Alzheimer’s

23rd August 2024

This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…

First UK conference on Body-Focused Repetitive Behaviours following Professor’s story about her own experience

20th August 2024

Oxford will host the first conference of its kind into body-focused repetitive behaviours (BFRBs) such as hair pulling and skin picking next month. It comes just over a year after…

Big Health celebrates big approval

12th August 2024

A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…

New study – Serotonin changes how people learn and respond to negative information

9th August 2024

Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…

Largest ever trial of ketamine-assisted therapy for alcohol disorder now recruiting

9th August 2024

The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants. The first patients are being screened to see if…

Could taking a specific anticonstipation drug reduce your risk of depression?

8th August 2024

In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…

Long-term cognitive and psychiatric effects of COVID-19 revealed in new study

1st August 2024

Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….

New Online Therapies Bring Oxford Mental Health Research to NHS Patients

31st July 2024

Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…

New shingles vaccine could reduce risk of dementia – major study indicates

25th July 2024

The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….

Recruitment open for healthy participants in the OxSENSE study

19th July 2024

University of Oxford and OH BRC supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of semaglutide…

New Therapeutic Approaches in Translational Mental Health

18th July 2024

Academia Meets Industry – Grand Challenges and New Horizons 16th September 2024, Mathematical Institute, Oxford The New Therapeutic Approaches in Translational Mental Health conference will bring together industry, academic and…

Mental Health and Diversity Research Study Findings Released

16th July 2024

New research from Oxford’s Department of Education has revealed the current picture of mental health and diversity support in schools in the Midlands. The research compiled feedback from 48 primary…

Have you participated in a mental health clinical trial?

12th July 2024

MQ Mental Health Research would like to hear form you if you have taken part in a mental health clinical trial that involved testing new medicines. They are putting together…

Oxford Health’s Clinical Research Facility (OH CRF) attend the 2024 UKCRF Network conference

10th July 2024

Staff from Oxford Health’s Clinical Research Facility (CRF) spent two engaging days at the UK CRF Network conference in Leicester from 4-5 July 2024. Although the event took place during…

OH BRC strategic partner University of Surrey host an Open Day

5th July 2024

Oxford Health BRC Researchers from the Universities of Birmingham, Oxford, Reading and Surrey met in Guildford on 1 July to tour the sleep facilities and discuss sleep technologies. At the…

OH BRC Brain Technologies Theme supports world’s first epilepsy device fitted into boy’s skull

27th June 2024

A study partnership involving University of Oxford researchers from the OH BRC’s Brain Technologies Theme, Great Ormond Street Hospital, University College London and King’s College Hospital were recently involved in…

New web pages for Oxford Health Clinical Research Facility (OH CRF)

25th June 2024

The Oxford Health Clinical Research Facility (OH CRF) web presence has been redeveloped and relaunched to better reflect the important work carried out. The OH CRF hosted by Oxford Health NHS…

Professor Rachel Upthegrove made MBE

17th June 2024

Professor Rachel Upthegrove, who joins the University of Oxfords Department of Psychiatry and our BRC as Director Designate in August, has been made an MBE in the King’s Birthday Honours…

Mood Disorder Research Clinic funding

28th May 2024

Launched 21 May 2024: Funding for new sites to join the Mood Disorder Research Clinic Network This is open to all Trusts across the 4 Nations. Please contact Julie Bieles…

Sarah Marr

Footer

Follow us

Improving brain health: the future in mind